{
    "clinical_study": {
        "@rank": "72207", 
        "arm_group": [
            {
                "arm_group_label": "No RenalGuard", 
                "arm_group_type": "No Intervention", 
                "description": "Control group will undergo CRT implantation without using RenalGuard"
            }, 
            {
                "arm_group_label": "RenalGuard", 
                "arm_group_type": "Experimental", 
                "description": "Use of the RenalGuard system during CRT implantation"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether the use of RenalGuard system which creates\n      high urine output with fluid balancing may prevent contrast induced nephropathy in patient\n      undergoing cardiac resynchronization therapy (CRT) implantation."
        }, 
        "brief_title": "The Use of Renal Guard System in Patients Undergoing CRT Implantation", 
        "completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Acute Kidney Injury", 
        "condition_browse": {
            "mesh_term": [
                "Acute Kidney Injury", 
                "Wounds and Injuries"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. eligible for CRT implantation\n\n          2. estimated GFR < 60ml/min/1.73m2\n\n        Exclusion Criteria:\n\n          1. On Dialysis\n\n          2. Sensitivity to Furosemide\n\n          3. Contraindication for urinary catheter\n\n          4. Pregnancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01936142", 
            "org_study_id": "TASMC-13-0167-YMICH"
        }, 
        "intervention": {
            "arm_group_label": "RenalGuard", 
            "intervention_name": "Use of RenalGuard", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Resynchroniztion therapy", 
            "Kidney", 
            "Contrast media", 
            "Prevention"
        ], 
        "lastchanged_date": "September 4, 2013", 
        "location": {
            "contact": {
                "email": "yoavm@tlvmc.gov.il", 
                "last_name": "Yoav Michowich, MD", 
                "phone": "972-52-4266064"
            }, 
            "facility": {
                "address": {
                    "city": "Tel Aviv", 
                    "country": "Israel", 
                    "zip": "64239"
                }, 
                "name": "Tel Aviv Souraky MC"
            }, 
            "investigator": {
                "last_name": "Yoav Michowich, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Effect of Forced Diuresis With Matched Hydration in Reducing Acute Kidney Injury During CRT Implantation", 
        "other_outcome": [
            {
                "measure": "Mortality", 
                "safety_issue": "Yes", 
                "time_frame": "6 month"
            }, 
            {
                "measure": "Hospitalization due to infection", 
                "safety_issue": "Yes", 
                "time_frame": "6 month"
            }
        ], 
        "overall_official": {
            "affiliation": "Tel Aviv Sourasky MC", 
            "last_name": "Yoav Michowich, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Israel: Ethics Commission", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Change in Renal function will be measured by change in serum creatinine (mg/dl)", 
            "measure": "Change in Renal function", 
            "safety_issue": "Yes", 
            "time_frame": "24 and 48 hours post implantation and 8-11 days post implantation, 6 month post implantaion"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01936142"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Tel-Aviv Sourasky Medical Center", 
            "investigator_full_name": "Michal Roll PhD,MBA", 
            "investigator_title": "Head of Research and Development Division", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Left ventricular lead implantation success", 
            "safety_issue": "No", 
            "time_frame": "1 day post implantation"
        }, 
        "source": "Tel-Aviv Sourasky Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Tel-Aviv Sourasky Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}